Replies to post #1802 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Tomix]

It can return to 0.25 very fast.

[n3m3sis]

hmmmm...I respect what you say Midas but I'm not buying (lol)it..

Remember, both of these drugs are bio-similars.
Companies that have the drugs that these are patterned on always run
the risk that the bio-similar might have greater efficacy and better
tolerance values than their own drug. Add to that the much reduced cost
of producing said bio-similar and the producers of the original
drug are going to have a big problem if that bio-similar is approved, fast track or otherwise.

Companies that produce the original drug in these cases are always
going to have contingency plans in case a promising bio-similar comes out that threatens their market.

What would you do if you were the director of a Big P company with a
gold standard drug and got wind of a small company
producing a bio-similar that more than likely would produce your drug to yesterdays news?